1700027N10Rik Activators encompass a chemical class designed to target and activate the "1700027N10Rik" gene. This gene plays a role in the regulation of various cellular functions. The search for these activators involves rigorous screening processes where a multitude of compounds are evaluated for their ability to increase gene expression. A commonly used technique in these screenings is the construction of a reporter assay. Here, the "1700027N10Rik" gene promoter is connected to a reporter gene, often luciferase, whose luminescent signal can be easily measured. When a compound successfully activates the promoter, the luciferase gene is transcribed, resulting in luminescence that is proportional to the activation level. Compounds that produce a significant rise in luminescence are singled out for more detailed study. This is a crucial step in the identification process as it allows for the selection of compounds with a specific effect on the activation of the "1700027N10Rik" gene.
Once potential activators have been identified through screening, a series of validation techniques are employed. Quantitative PCR (qPCR) is utilized to determine the level of mRNA produced by the "1700027N10Rik" gene after the application of these compounds. An increase in mRNA levels, as indicated by qPCR, confirms that the transcription of the gene is being upregulated by the activator compounds. The next step is to verify this increase at the protein level via Western blot analysis. This technique will show whether the increased mRNA results in a corresponding increase in the "1700027N10Rik" protein. It also provides data on the protein's expression, stability, and post-translational modifications that may occur due to the interaction with the activators. The combination of qPCR and Western blot results can confirm the direct effect of the activators on the gene's expression pathway from transcription through to protein synthesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. Elevated calcium levels can activate calcium-dependent protein kinases, which may phosphorylate and thus enhance the activity of "1700027N10Rik". | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). Activation of PKC can lead to phosphorylation and activation of downstream proteins, potentially including "1700027N10Rik". | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, similar to Forskolin, thereby activating PKA and possibly leading to the phosphorylation and activation of "1700027N10Rik". | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a bioactive lipid that activates S1P receptors, triggering signaling pathways that may lead to the activation of "1700027N10Rik" through downstream kinases. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its nuclear receptors, which can regulate gene expression and potentially lead to the production of proteins that interact with and activate "1700027N10Rik". | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then phosphorylate various proteins, possibly including "1700027N10Rik", to enhance its activity. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide serves as a signaling molecule that can activate various kinases through oxidative signaling pathways, potentially influencing the functional activity of "1700027N10Rik". | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a stable cAMP analog that activates PKA, potentially leading to the phosphorylation and subsequent activation of "1700027N10Rik". | ||||||
NOC-18 | 146724-94-9 | sc-202247 sc-202247A sc-202247B sc-202247C | 10 mg 50 mg 100 mg 500 mg | $51.00 $184.00 $305.00 $1122.00 | 18 | |
Nitric oxide donors release nitric oxide, which can activate guanylyl cyclase and increase cGMP levels, possibly leading to the activation of protein kinases that could phosphorylate and enhance "1700027N10Rik". | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate multiple signaling pathways, including inhibition of certain kinases, potentially altering the phosphorylation state and activity of "1700027N10Rik". | ||||||